Showing results (221-230 of 258) with videos related to
Sort By:
Pageof 26
Bonekey Reports|August 15, 2014
Enhanced osteoblastogenesis in three-dimensional collagen gelsBrya G Matthews, Dorit Naot, Karen E Callon, et al.Calcified Tissue International|June 29, 2019
Long-Term Stable Bone Mineral Density in HIV-Infected Men Without Risk Factors for Osteoporosis Treated with Antiretroviral TherapyMark J Bolland, Anne M Horne, Simon E Briggs, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 2007
Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanismsSusannah O'Sullivan, Dorit Naot, Karen Callon, et al.Biochemical and Biophysical Research Communications|November 26, 2009
Evidence for a role for the p110-alpha isoform of PI3K in skeletal functionAndrew Grey, Claire Chaussade, Victoria Empson, et al.Molecular Endocrinology (Baltimore, Md.)|June 5, 2004
The low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cellsAndrew Grey, Tatjana Banovic, Qing Zhu, et al.Human Molecular Genetics|October 11, 2002
Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's diseaseLynne J Hocking, Gavin J A Lucas, Anna Daroszewska, et al.Biochemical and Biophysical Research Communications|April 28, 2004
Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1Jillian Cornish, Andrew Grey, Karen E Callon, et al.Archives of Internal Medicine|November 13, 2008
Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older menIan R Reid, Ruth Ames, Barbara Mason, et al.BMJ (Clinical Research Ed.)|January 17, 2008
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trialMark J Bolland, P Alan Barber, Robert N Doughty, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2006
Deletion of aspartate 182 in OPG causes juvenile Paget's disease by impairing both protein secretion and binding to RANKLCatherine Middleton-Hardie, Qing Zhu, Harry Cundy, et al.Pageof 26